| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |